Intravenous Contrast-Enhanced Ultrasound for Assessing and Grading Postoperative Recurrence of Crohn's Disease

Dig Dis Sci. 2019 Jun;64(6):1640-1650. doi: 10.1007/s10620-018-5432-6. Epub 2019 Jan 2.

Abstract

Purpose: The aim was to investigate the contribution of contrast-enhanced ultrasound (CEUS) to improve the results of US in the evaluation of recurrence in postsurgical Crohn's disease (CD) and establish its role in the assessment of the severity.

Methods: Anastomotic site was assessed in 108 postsurgical CD patients with B-mode, color Doppler and CEUS. Bowel wall thickness (WT), transmural complications or stenosis, color Doppler grade, and bowel wall contrast enhancement (BWCE)-using time-intensity curves-were correlated with endoscopic Rutgeerts score. A receiver operating characteristic (ROC) curve was built to establish the best cutoff to predict recurrence and the severity. A US scoring system was elaborated in order to determine the grade of recurrence.

Results: Ileocolonoscopy detected recurrence in 90 (83.3%) subjects and severe recurrence in 62. WT ≥ 3 mm had an accuracy of 90.7% in the detection of endoscopic recurrence. The combination of parameters-WT ≥ 3 mm and BWCE (≥ 46%)-demonstrated similar accuracy (90.7%). A WT ≥ 5 mm showed the best specificity (100%) for the diagnosis of recurrence and a WT ≥ 6 mm the best specificity (95.7%) for the detection of severe recurrence. The combination of sonographic parameters-WT ≥ 6 mm or WT between 5 and 6 mm with BWCE ≥ 70%, or complications-obtained the best results grading the recurrence (sensitivity, specificity, and accuracy of 90.3%, 87%, and 88.9%, respectively).

Conclusions: US shows high sensitivity and specificity for the diagnosis of postsurgical recurrence. When combined with CEUS, it can improve the detection of severe recurrence.

Keywords: Bowel sonography; Contrast-enhanced ultrasound; Crohn’s disease; Postsurgical recurrence.

MeSH terms

  • Administration, Intravenous
  • Adolescent
  • Adult
  • Aged
  • Colonoscopy
  • Contrast Media / administration & dosage*
  • Crohn Disease / diagnostic imaging*
  • Crohn Disease / surgery*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Observer Variation
  • Phospholipids / administration & dosage*
  • Predictive Value of Tests
  • Prospective Studies
  • Recurrence
  • Reproducibility of Results
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Sulfur Hexafluoride / administration & dosage*
  • Treatment Outcome
  • Ultrasonography, Doppler, Color*
  • Young Adult

Substances

  • Contrast Media
  • Phospholipids
  • contrast agent BR1
  • Sulfur Hexafluoride